RxDoctor Payments Data

Anne Stahl-Hughitt

Nurse Practitioner · Orange, CANPI 1629126560

Payments from drug & device makers

$3,770in general payments, 2019–2025

Across 192 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$522
  • Lilly USA, LLC$309
  • Novartis$300
  • Novo Nordisk$276
  • Boehringer Ingelheim$273
  • Amgen$269
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$3,770100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,770 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$15,056
SynthroidLevothyroxine Sodium12$1,099
Levothyroxine Sodium64$856
Atorvastatin Calcium103$846
Fluticasone Propionate25$649
Omeprazole40$569
Losartan Potassium51$562
Rosuvastatin Calcium44$542
Albuterol Sulfate HfaAlbuterol Sulfate22$494
Gabapentin20$447
Ezetimibe15$433
Potassium Chloride16$406
Metoprolol Succinate25$392
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril14$335
Tamsulosin Hcl18$306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$276$15,05613 claims
AbbVieSynthroid$522$1,09912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →